Please login to the form below

Not currently logged in
Email:
Password:

MC Services welcomes Dr Claudia Gutjahr-Loeser to its management team

She joins the PR firm from MorphoSys, where she was senior VP

Claudia GutjahInvestor and public relations firm MC Services has appointed Dr Claudia Gutjahr-Loeser as its managing director.

She joins the Duesseldorf, Germany-based firm from MorphoSys, where she headed the corporate communications and investor relations department as senior vice president; a role that saw her took responsibility for external communications activities and international investor relations.

Prior to that, Dr Gutjah-Loeser worked at Cassiopeia and Deutsche Bank in various capacities, as well as co-founding and leading Communications and Public Relations.

Raimund Gabriel, managing partner of MC Services, said: “Claudia is one of the rare investor relations professionals who is recognised and respected both in Europe and in the United States.

“She brings a wealth of international investor relations experience and capital markets transaction expertise to MC Services and will be of great support and value for the growing number of our clients operating in transatlantic settings.”

25th October 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics